Hospital News and Research RSS Feed - Hospital News and Research

Antibiotic exposure in infancy linked to childhood obesity

Antibiotic exposure in infancy linked to childhood obesity

Repeated exposure to broad-spectrum antibiotics in the first two years of life is associated with early childhood obesity, say researchers from The Children's Hospital of Philadelphia in a retrospective study based on data from electronic health records from the extensive CHOP Care Network. [More]
Specific nurse-to-patient staffing standards lower job-related injuries, illnesses for nurses

Specific nurse-to-patient staffing standards lower job-related injuries, illnesses for nurses

A 2004 California law mandating specific nurse-to-patient staffing standards in acute care hospitals significantly lowered job-related injuries and illnesses for both registered nurses and licensed practical nurses, according to UC Davis research published online in the International Archives of Occupational and Environmental Health. [More]
Neuropsychiatric symptoms variable in early Parkinson’s disease

Neuropsychiatric symptoms variable in early Parkinson’s disease

The prevalence of neuropsychiatric symptoms is increased in patients with early Parkinson’s disease, although many remain stable over time, shows follow-up of the Parkinson’s Progression Markers Initiative. [More]
Targeted treatments may improve idiopathic PAH survival

Targeted treatments may improve idiopathic PAH survival

Patients with idiopathic pulmonary arterial hypertension may live longer if they are given targeted treatments than if they receive conventional management, researchers suggest. [More]
Weekly musculoskeletal pain on the rise among young adults

Weekly musculoskeletal pain on the rise among young adults

Research from Finland shows an increase in the prevalence of frequent musculoskeletal symptoms in young adults, which suggests the need for early intervention. [More]
Christiana Care Health System wins 2014 Health Devices Achievement Award

Christiana Care Health System wins 2014 Health Devices Achievement Award

ECRI Institute is pleased to announce Christiana Care Health System, Wilmington, DE, as the winner of its 9th Annual Health Devices Achievement Award. [More]
Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals Ltd. ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT™ devices and accessories from Itamar Medical Ltd. [More]
Raritan Bay Medical Center accepts customer service inquiries via Twitter

Raritan Bay Medical Center accepts customer service inquiries via Twitter

Raritan Bay Medical Center announces it will begin to accept customer service inquiries via Twitter, the social media website. [More]
Bigger challenges forecast for health law's second enrollment drive

Bigger challenges forecast for health law's second enrollment drive

Enrolling new customers will be more complicated this time around because potential enrollees may be harder to reach, reports The Wall Street Journal. [More]
Survey: Many patients not always well informed about treatment options

Survey: Many patients not always well informed about treatment options

More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain. [More]
Report: Too few staff to care for children admitted to intensive care units

Report: Too few staff to care for children admitted to intensive care units

More children than ever are being admitted to intensive care units in England and Wales but there are fewer staff per bed available to cope with the increase, according to a new report published jointly by the University of Leeds and University of Leicester. [More]
Researchers create new Cas9 animal model for in vivo genome editing experiments

Researchers create new Cas9 animal model for in vivo genome editing experiments

Researchers from the Broad Institute and Massachusetts Institute of Technology have created a new mouse model to simplify application of the CRISPR-Cas9 system for in vivo genome editing experiments. [More]
Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

The transplantation of faecal microbiota from a healthy donor has been shown in recent clinical studies to be a safe and highly effective treatment for recurrent Clostridium difficile (C. difficile) infection and is now recommended in European treatment guidelines. [More]
Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

A new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia and cachexia, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain. [More]
Chemotherapy, radiotherapy have no negative effect on unborn babies

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown. [More]
Phase III trial: Rolapitant lessens chemotherapy-induced nausea and vomiting

Phase III trial: Rolapitant lessens chemotherapy-induced nausea and vomiting

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain. [More]
Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9. [More]
Scientists discover sign of early development of pancreatic cancer

Scientists discover sign of early development of pancreatic cancer

Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer - an upsurge in certain amino acids that occurs before the disease is diagnosed and symptoms appear. [More]
Rogers Behavioral Health System opens treatment center in Tampa, Fla.

Rogers Behavioral Health System opens treatment center in Tampa, Fla.

Rogers Behavioral Health System, Wisconsin's largest, not-for-profit mental health and addiction services provider, is opening its first treatment center outside of Wisconsin in Tampa, Fla., on Monday, September 29. [More]
EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for Oncology Innovation (GOI), who will receive grants totaling $1.3 million. [More]